Daily Oral Grepafloxacin vs. Twice Daily Oral Doxycycline in the Treatment ofChlamydia trachomatisEndocervical Infection
نویسندگان
چکیده
منابع مشابه
Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.
OBJECTIVE To compare the efficacy and safety of a 7-day course of treatment with oral grepafloxacin, 400 mg once daily, and oral doxycycline, 100 mg twice daily, in patients with chlamydial cervicitis. METHODS Women aged 18 years or older attending 17 sexually transmitted disease clinics in the United States who had clinical signs of mucopurulent cervicitis or who had a recent positive cultur...
متن کاملSimple conversion from intravenous aminophylline to twice daily oral theophylline.
Communications for this section will be published as space and priorities permit. The comments should not exceed 350 words in length, with a maximum office references; onefigure or table can be printed. Exceptions may occur under particular circumstances. Contributions may include comments on articles published in this periodical, or they may be reports ofunique educational character Spec fic p...
متن کاملOral impact on daily performance in Iranian adults
BACKGROUND AND AIM: The aim of this study was to evaluate the prevalence and severity of oral impact on daily performance (OIDP) in adults attending dental clinics in the city of Kerman, Iran. METHODS: In 2010, a cross-sectional survey was conducted on a sample of 400 patients (age 20-50 years) referring to dental centers in Kerman. Validated OIDP inventory was used to collect data. Clinical ex...
متن کاملOral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women.
Iron supplements acutely increase hepcidin, but the duration and magnitude of the increase, its dose dependence, and its effects on subsequent iron absorption have not been characterized in humans. Better understanding of these phenomena might improve oral iron dosing schedules. We investigated whether the acute iron-induced increase in hepcidin influences iron absorption of successive daily ir...
متن کاملWeek 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients.
OBJECTIVE ODIN (Once-daily Darunavir In treatment-experieNced patients) was a phase III, 48-week, open-label study comparing once-daily vs. twice-daily darunavir/ritonavir (DRV/r) in treatment-experienced patients with no DRV resistance-associated mutations (RAMs) at screening. METHODS Patients with no DRV RAMs and receiving stable HAART for at least 12 weeks were stratified by HIV-1 RNA (≤ o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Infectious Diseases in Obstetrics and Gynecology
سال: 1998
ISSN: 1064-7449,1098-0997
DOI: 10.1155/s1064744998000210